HomeNGENF • OTCMKTS
add
NervGen Pharma Corp
Previous close
$2.71
Day range
$2.50 - $2.78
Year range
$1.46 - $5.10
Market cap
260.01M CAD
Avg Volume
381.72K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.04M | 21.45% |
Net income | -3.95M | -68.34% |
Net profit margin | — | — |
Earnings per share | -0.06 | -50.00% |
EBITDA | -6.02M | -22.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.47M | -52.25% |
Total assets | 15.84M | -50.17% |
Total liabilities | 14.45M | 11.51% |
Total equity | 1.39M | — |
Shares outstanding | 71.94M | — |
Price to book | 135.65 | — |
Return on assets | -85.42% | — |
Return on capital | -726.53% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.95M | -68.34% |
Cash from operations | -4.12M | -26.83% |
Cash from investing | 25.23K | — |
Cash from financing | 1.27M | -94.21% |
Net change in cash | -2.80M | -115.00% |
Free cash flow | -3.90M | 5.31% |
About
Founded
2017
Headquarters
Website
Employees
10
